Literature DB >> 12864952

Evaluation of bone mineral density in patients with inflammatory bowel disease.

Carmen Cuffari1, Gary R Lichtenstein.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12864952     DOI： 10.1007/s11894-003-0059-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


× No keyword cloud information.
  10 in total

1.  Bone mineral density in patients with recently diagnosed inflammatory bowel disease.

Authors:  E J Schoon; B M Blok; B J Geerling; M G Russel; R W Stockbrügger; R J Brummer
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

2.  Bone mineral density assessment in children with inflammatory bowel disease.

Authors:  R Gokhale; M J Favus; T Karrison; M M Sutton; B Rich; B S Kirschner
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

Review 3.  Glucocorticoid-induced osteoporosis: pathogenesis and management.

Authors:  B P Lukert; L G Raisz
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

Review 4.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

5.  Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.

Authors:  J D Adachi; W G Bensen; F Bianchi; A Cividino; S Pillersdorf; R J Sebaldt; P Tugwell; M Gordon; M Steele; C Webber; C H Goldsmith
Journal:  J Rheumatol       Date:  1996-06       Impact factor: 4.666

6.  Genetic factors determine extent of bone loss in inflammatory bowel disease.

Authors:  C M Schulte; A U Dignass; H Goebell; H D Röher; K M Schulte
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

7.  Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.

Authors:  D M Reid; R A Hughes; R F Laan; N A Sacco-Gibson; D H Wenderoth; S Adami; R A Eusebio; J P Devogelaer
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

Review 8.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

9.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

10.  Bone loss in patients with inflammatory bowel disease: a prospective study.

Authors:  C Roux; V Abitbol; S Chaussade; S Kolta; S Guillemant; M Dougados; B Amor; D Couturier
Journal:  Osteoporos Int       Date:  1995-05       Impact factor: 4.507
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.